Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting
Resumen
Palabras clave
Criterios de consenso; Fase inicial; Neuroblastoma
Citación recomendada
Park JR, Villablanca JG, Hero B, Kushner BH, Wheatley K, Beiske KH, et al. Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer. 2022 Nov 1;128(21):3775–83.
Audiencia
Professionals
Usar este identificador para citar y/o enlazar este documento
https://hdl.handle.net/11351/8463Este elemento aparece en las siguientes colecciones
- HVH - Articles científics [2980]
El ítem tiene asociados los siguientes ficheros de licencia: